INFINIMMUNE Trademark
Trademark Overview
On Tuesday, March 7, 2023, a trademark application was filed for INFINIMMUNE with the United States Patent and Trademark Office. The USPTO has given the INFINIMMUNE trademark a serial number of 97827376. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Sunday, December 15, 2024. This trademark is owned by Infinimmune, Inc.. The INFINIMMUNE trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
downloadable computer software for the visualization and analysis of biological data for biomolecular research and the design and engineering of biomolecular products; downloadable computer software in the field of drug design and development
pharmaceutical preparations featuring antibodies for medical purposes for the treatment of autoimmune diseases, cardiovascular disease, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genetic diseases and disorders, infectious diseases, inflammatory diseases, kidney disease, liver disease, metabolic diseases and disorders, musculoskeletal disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations with protein expression for the treatment of autoimmune diseases, cardiovascular disease, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genetic diseases and disorders, infectious diseases, inflammatory diseases, kidney disease, liver disease, metabolic diseases and disord...
providing medical services and medical information in the fields of immunology, single cell technologies, protein engineering, computational biology, genome assembly and DNA sequencing
medical research and development in the fields of immunology, single cell technologies, protein engineering, computational biology, genome assembly and DNA sequencing and scientific research and development; medical research and development and scientific research and development in the fields of immunology, single cell technologies, protein engineering, computational biology, genome assembly and DNA sequencing; pharmaceutical drug development services; providing temporary use of online non-downloadable software for the visualization and analysis of biological data for biomolecular research and the design and engineering of biomolecular products; providing temporary use of online non-downloadable software in the field of drug design and development
General Information
Serial Number | 97827376 |
Word Mark | INFINIMMUNE |
Filing Date | Tuesday, March 7, 2023 |
Status | 730 - FIRST EXTENSION - GRANTED |
Status Date | Sunday, December 15, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 30, 2024 |
Trademark Statements
Goods and Services | downloadable computer software for the visualization and analysis of biological data for biomolecular research and the design and engineering of biomolecular products; downloadable computer software in the field of drug design and development |
Goods and Services | pharmaceutical preparations featuring antibodies for medical purposes for the treatment of autoimmune diseases, cardiovascular disease, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genetic diseases and disorders, infectious diseases, inflammatory diseases, kidney disease, liver disease, metabolic diseases and disorders, musculoskeletal disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations with protein expression for the treatment of autoimmune diseases, cardiovascular disease, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genetic diseases and disorders, infectious diseases, inflammatory diseases, kidney disease, liver disease, metabolic diseases and disorders, musculoskeletal disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes |
Goods and Services | providing medical services and medical information in the fields of immunology, single cell technologies, protein engineering, computational biology, genome assembly and DNA sequencing |
Goods and Services | medical research and development in the fields of immunology, single cell technologies, protein engineering, computational biology, genome assembly and DNA sequencing and scientific research and development; medical research and development and scientific research and development in the fields of immunology, single cell technologies, protein engineering, computational biology, genome assembly and DNA sequencing; pharmaceutical drug development services; providing temporary use of online non-downloadable software for the visualization and analysis of biological data for biomolecular research and the design and engineering of biomolecular products; providing temporary use of online non-downloadable software in the field of drug design and development |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, March 28, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, March 28, 2023 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, March 28, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, March 28, 2023 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Infinimmune, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Alameda, CA 94502 |
Party Name | Infinimmune, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Alameda, CA 94502 |
Trademark Events
Event Date | Event Description |
Thursday, July 13, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Friday, March 10, 2023 | NEW APPLICATION ENTERED |
Tuesday, March 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, July 13, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Thursday, July 13, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, July 14, 2023 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Friday, July 14, 2023 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
Tuesday, December 5, 2023 | ASSIGNED TO EXAMINER |
Friday, December 29, 2023 | NON-FINAL ACTION WRITTEN |
Friday, December 29, 2023 | NON-FINAL ACTION E-MAILED |
Friday, December 29, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, February 23, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, February 23, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, February 23, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, April 10, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, March 25, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, April 30, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, June 25, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, November 12, 2024 | SOU EXTENSION 1 FILED |
Monday, December 16, 2024 | SOU EXTENSION 1 GRANTED |
Monday, December 16, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, December 12, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Tuesday, April 30, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 12, 2024 | SOU TEAS EXTENSION RECEIVED |